Citi analyst Samantha Semenkow raised the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $31.00 (from $27.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form 8-K CATALYST PHARMACEUTICALS For: Aug 07August 7, 2024 4:37 PM Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 33c, Beats on Revenue; Offers FY24 Revenue GuidanceAugust 7, 2024 4:24 PM Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 7, 2024 4:11 PM Form 10-Q CATALYST PHARMACEUTICALS For: Jun 30August 7, 2024 4:07 PM Eight defensive growth stocks to own right nowAugust 7, 2024 10:00 AM